Zobrazeno 1 - 10
of 6 143
pro vyhledávání: '"Grunwald T"'
Autor:
Bergs, T., Schwaneberg, U., Barth, S., Hermann, L., Grunwald, T., Mayer, S., Biermann, F., Sözer, N.
Publikováno v:
In CIRP Journal of Manufacturing Science and Technology August 2021 34:95-104
Autor:
Herrmann A; Immunic AG, Gräfelfing, Germany. Electronic address: alexandra.herrmann@imux.com., Gege C; Immunic AG, Gräfelfing, Germany. Electronic address: christian.gege@imux.com., Wangen C; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: christina.wangen@uk-erlangen.de., Wagner S; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: sabrina.wagner@uk-erlangen.de., Kögler M; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: melanie.koegler@uk-erlangen.de., Cordsmeier A; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: arne.cordsmeier@uk-erlangen.de., Irrgang P; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: pascal.irrgang@uk-erlangen.de., Ip WH; Leibniz Institute of Virology, Hamburg, Germany. Electronic address: winghang.ip@leibniz-liv.de., Weil T; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: tatjanaweil@yahoo.de., Hunszinger V; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: victoria.hunszinger@uni-ulm.de., Groß R; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: ruediger.gross@uni-ulm.de., Heinen N; Ruhr-University Bochum, Department of Molecular and Medical Virology, Bochum, Germany. Electronic address: natalie.heinen@ruhr-uni-bochum.de., Pfaender S; Leibniz Institute of Virology, Hamburg, Germany; Ruhr-University Bochum, Department of Molecular and Medical Virology, Bochum, Germany; University of Luebeck, Department of Natural Sciences, Institute of Virology and Cell Biology, Lübeck, Germany. Electronic address: stephanie.pfaender@leibniz-liv.de., Reuter S; University Hospital Essen - Ruhrlandklinik, Department of Pulmonary Medicine, Experimental Pneumology, Essen, Germany. Electronic address: sebastian.reuter@rlk.uk-essen.de., Klopfleisch R; Institute for Animal Pathology, Freie Universität Berlin, Berlin, Germany. Electronic address: robert.klopfleisch@fu-berlin.de., Uhlig N; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: nadja.uhlig@izi.fraunhofer.de., Eberlein V; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: valentina.eberlein@izi.fraunhofer.de., Issmail L; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: leila.issmail@izi.fraunhofer.de., Grunwald T; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: thomas.grunwald@izi.fraunhofer.de., Hietel B; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Halle, Germany. Electronic address: benjamin.hietel@izi.fraunhofer.de., Cynis H; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Halle, Germany; Junior Research Group 'Immunomodulation in Pathophysiological Processes', Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany. Electronic address: holger.cynis@izi.fraunhofer.de., Münch J; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: jan.muench@uni-ulm.de., Sparrer KMJ; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: konstantin.sparrer@uni-ulm.de., Ensser A; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: armin.ensser@fau.de., Tenbusch M; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: matthias.tenbusch@fau.de., Dobner T; Leibniz Institute of Virology, Hamburg, Germany. Electronic address: thomas.dobner@leibniz-liv.de., Vitt D; Immunic AG, Gräfelfing, Germany. Electronic address: daniel.vitt@imux.com., Kohlhof H; Immunic AG, Gräfelfing, Germany. Electronic address: hella.kohlhof@imux.com., Hahn F; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: friedrich.hahn@uk-erlangen.de.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Nov; Vol. 231, pp. 106008. Date of Electronic Publication: 2024 Sep 19.
Autor:
Gege C; Immunic AG, Lochhamer Schlag 21, 82166, Gräfelfing, Germany., Hahn F; Institute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Schlossgarten 4, 91054, Erlangen, Germany., Wangen C; Institute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Schlossgarten 4, 91054, Erlangen, Germany., Häge S; Institute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Schlossgarten 4, 91054, Erlangen, Germany., Herrmann A; Immunic AG, Lochhamer Schlag 21, 82166, Gräfelfing, Germany., Uhlig N; Department of Vaccines and Infection Models, Unit Preclinical Validation, Fraunhofer-Institute for Cell Therapy and Immunology IZI, Perlickstrasse 1, 04103, Leipzig, Germany., Eberlein V; Department of Vaccines and Infection Models, Unit Preclinical Validation, Fraunhofer-Institute for Cell Therapy and Immunology IZI, Perlickstrasse 1, 04103, Leipzig, Germany., Issmail L; Department of Vaccines and Infection Models, Unit Preclinical Validation, Fraunhofer-Institute for Cell Therapy and Immunology IZI, Perlickstrasse 1, 04103, Leipzig, Germany., Klopfleisch R; Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag-Str. 15, 14163, Berlin, Germany., Grunwald T; Department of Vaccines and Infection Models, Unit Preclinical Validation, Fraunhofer-Institute for Cell Therapy and Immunology IZI, Perlickstrasse 1, 04103, Leipzig, Germany., Marschall M; Institute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Schlossgarten 4, 91054, Erlangen, Germany., Kohlhof H; Immunic AG, Lochhamer Schlag 21, 82166, Gräfelfing, Germany., Vitt D; Immunic AG, Lochhamer Schlag 21, 82166, Gräfelfing, Germany.
Publikováno v:
ChemMedChem [ChemMedChem] 2024 Oct 01; Vol. 19 (19), pp. e202400292. Date of Electronic Publication: 2024 Aug 06.
Autor:
Bergs, T., Schwaneberg, U., Barth, S., Hermann, L., Grunwald, T., Mayer, S., Biermann, F., Sözer, N.
Publikováno v:
In CIRP Journal of Manufacturing Science and Technology November 2020 31:68-77
Autor:
Stahl-Hennig C; Unit of Infection Models, German Primate Center, Göttingen, Germany., Peter AS; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Cordsmeier A; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Stolte-Leeb N; Unit of Infection Models, German Primate Center, Göttingen, Germany., Vestweber R; Unit of Infection Models, German Primate Center, Göttingen, Germany., Socher E; Institute of Anatomy, Functional and Clinical Anatomy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Merida SA; Unit of Infection Models, German Primate Center, Göttingen, Germany., Sauermann U; Unit of Infection Models, German Primate Center, Göttingen, Germany., Bleyer M; Unit of Infection Models, German Primate Center, Göttingen, Germany., Fraedrich K; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Grunwald T; Department of Vaccines and Infection Models, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany., Winkler TH; Division of Genetics, Department Biology, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Ensser A; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Jäck H-M; Division of Molecular Immunology, Internal Medicine III, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Überla K; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Publikováno v:
Journal of virology [J Virol] 2024 Jul 23; Vol. 98 (7), pp. e0062824. Date of Electronic Publication: 2024 Jun 20.
Autor:
Wagner JT; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Müller-Schmucker SM; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Wang W; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands., Arnold P; Institute of Functional and Clinical Anatomy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Uhlig N; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Preclinical Validation, Leipzig, Germany., Issmail L; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Preclinical Validation, Leipzig, Germany., Eberlein V; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Preclinical Validation, Leipzig, Germany., Damm D; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Roshanbinfar K; Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Ensser A; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Oltmanns F; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Peter AS; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Temchura V; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Schrödel S; Sirion Biotech GmbH, Graefelfing, Germany., Engel FB; Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Thirion C; Sirion Biotech GmbH, Graefelfing, Germany., Grunwald T; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Preclinical Validation, Leipzig, Germany., Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands., Grimm D; Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty and Faculty of Engineering Sciences, University of Heidelberg; BioQuant Center, BQ0030, University of Heidelberg; German Center for Infection Research (DZIF), German Center for Cardiovascular Research (DZHK), partner site, Heidelberg, Germany., Überla K; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. klaus.ueberla@fau.de.
Publikováno v:
Communications biology [Commun Biol] 2024 Jul 16; Vol. 7 (1), pp. 865. Date of Electronic Publication: 2024 Jul 16.
Autor:
Li, Yi1 (AUTHOR)
Publikováno v:
Epilepsy Currents. Jul/Aug2024, Vol. 24 Issue 4, p251-253. 3p.
We present a new wavelet based method for the denoising of {\it event related potentials} ERPs), employing techniques recently developed for the paradigm of deterministic chaotic systems. The denoising scheme has been constructed to be appropriate fo
Externí odkaz:
http://arxiv.org/abs/physics/0001069
Autor:
Eberlein V; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Rosencrantz S; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Applied Polymer Research (IAP), Potsdam, Germany., Finkensieper J; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Besecke JK; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology (FEP), Dresden, Germany., Mansuroglu Y; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Frankfurt, Germany., Kamp JC; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany., Lange F; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Dressman J; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Frankfurt, Germany., Schopf S; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology (FEP), Dresden, Germany., Hesse C; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany., Thoma M; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.; Fraunhofer Institute for Manufacturing Engineering and Automation (IPA), Stuttgart, Germany., Fertey J; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Ulbert S; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany., Grunwald T; Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Apr 05; Vol. 15, pp. 1382318. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.